eujobs.coEU jobs in brussels
Post a JobHeadhunter

CSL Behring

General Information

Identification Code: 030031840349-92
Website: [object Object]
Entity Form: LLC
Registration Category: Companies & groups
Registration Date: 11/17/2020
Last Update: 4/9/2024
EP Accredited Number: 0

Mission & Interests

Goals: CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives. We have R&D and manufacturing sites across four continents, and specifically in Europe in Marburg, Germany and Bern, Switzerland.
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
  • Budget
  • Competition
  • Digital economy and society
  • Humanitarian aid and civil protection
  • Institutional affairs
  • Public health
  • Research and innovation
  • Single market
  • Taxation
  • Trade
Levels of Interest:
  • global

Activities

Main EU Legislative Proposals: Pharmaceutical Strategy (including OMP legislation) SoHO legislation Industrial Strategy European Health Union and Preparedness Trade Strategy Open Strategic Autonomy Critical Medicines Act
Communication Activities: Economist Impact Cell & Gene Therapy Summit: on EU access to ATMPs (April 2023) European Health Summit (June 2023) on resilience of health systems World Orphan Drug Congress (Nov 2023) on clinical trials designs to support access to ATMPs in Europe Publication of Company Response to the public consultation on the EU General Pharma Legislation (Nov 2023)
Inter-institutional or Unofficial Groupings: N/A

Head Office

Address: 1020 First Avenue
Post Code: PA 19406-0901 USA
City: King of Prussia
Country: UNITED STATES
Phone: [object Object]

EU Office

Address: Bedrijvenlaan
Post Code: 28000
City: Mechelen
Country: BELGIUM
Phone: [object Object]

Financial Data

New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]
Complementary Information: Information under 14. covers our closed financial year between July 2022 and June 2023. This may lead to discrepancies in figures reported by our intermediaries whose financial year runs from January to December.

Membership Information

Members10 Percent: 0
Members25 Percent: 0
Members50 Percent: 3
Members75 Percent: 0
Members: 3
Members F T E: 1.5

Structure

Structure Type: Structure
Is Member Of: Transform Alliance https://transformalliance.eu/
Organisation Members: Eucope - The European Confederation of Pharmaceutical Entrepreneurs ARM - The Alliance for Regenerative Medicine Europabio - The European Association for Bioindustries EFPIA - The European Federation of Pharmaceutical Industries and Associations